Pablo Tamayo

Q: What Schools Are Affiliated With Pablo Tamayo

Pablo Tamayo is affiliated with the following schools: University of California, San Diego, Massachusetts Institute of Technology, Stanford University, Johns Hopkins University, Harvard University

Pablo Tamayo's AcademicInfluence.com Rankings

Pablo Tamayo

Computer Science

#5289

World Rank

#5587

Historical Rank

Algorithms

#181

World Rank

#184

Historical Rank

Machine Learning

#1344

World Rank

#1365

Historical Rank

Database

#2446

World Rank

#2563

Historical Rank

computer-science Degrees

Pablo Tamayo

Biology

#7965

World Rank

#10969

Historical Rank

Bioinformatics

#88

World Rank

#90

Historical Rank

Computational Biology

#149

World Rank

#149

Historical Rank

biology Degrees

Download Badge

Computer Science
Biology

Pablo Tamayo's Degrees

PhD Bioinformatics University of California, San Diego
Masters Computer Science Stanford University
Bachelors Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Pablo Tamayo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pablo Tamayo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles (2005) (33800)
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. (1999) (12024)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes (2003) (6859)
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. (2010) (5816)
The Molecular Signatures Database Hallmark Gene Set Collection (2015) (4513)
Molecular signatures database (MSigDB) 3.0 (2011) (3692)
Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. (1999) (3275)
The Molecular Signatures Database (MSigDB) hallmark gene set collection. (2015) (2763)
Gene expression correlates of clinical prostate cancer behavior. (2002) (2549)
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning (2002) (2443)
Prediction of central nervous system embryonal tumour outcome based on gene expression (2002) (2421)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 (2009) (2300)
Multiclass cancer diagnosis using tumor gene expression signatures (2001) (2107)
GenePattern 2.0 (2006) (1785)
Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data (2003) (1757)
Metagenes and molecular pattern discovery using matrix factorization (2004) (1750)
GSEA-P: a desktop application for Gene Set Enrichment Analysis (2007) (1121)
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. (2003) (952)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway (2017) (911)
SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas (2009) (904)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen (2007) (902)
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. (2000) (855)
MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS (2012) (686)
Chemosensitivity prediction by transcriptional profiling (2001) (663)
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. (2011) (643)
Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. (2000) (639)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity (2008) (630)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells (2009) (546)
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. (2012) (509)
Automated high-dimensional flow cytometric data analysis (2009) (434)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer (2011) (412)
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. (2014) (412)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets (2007) (369)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak (2010) (362)
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies (2014) (320)
Molecular classification of multiple tumor types (2001) (291)
Estimating Dataset Size Requirements for Classifying DNA Microarray Data (2003) (272)
Class prediction and discovery using gene expression data (2000) (248)
Distinct physiological states of Plasmodium falciparum in malaria-infected patients (2007) (246)
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway (2010) (217)
Support vector ma-chine classification of microarray data (2000) (211)
Microarray data mining: facing the challenges (2003) (206)
Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. (2016) (202)
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. (2005) (199)
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. (2007) (196)
Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. (2018) (184)
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses (2018) (180)
MYC regulation of a “poor-prognosis” metastatic cancer cell state (2010) (173)
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines (2016) (172)
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 (2012) (171)
An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome (2008) (170)
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. (2014) (167)
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies (2014) (161)
High-throughput Phenotyping of Lung Cancer Somatic Mutations. (2016) (157)
Metagene projection for cross-platform, cross-species characterization of global transcriptional states (2007) (152)
A functional landscape of resistance to ALK inhibition in lung cancer. (2015) (151)
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. (2013) (137)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. (2019) (133)
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth. (2014) (125)
A resampling-based method for class discovery and visualization of gene expression microarray data (2003) (125)
A genetic basis for the variation in the vulnerability of cancer to DNA damage (2016) (124)
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles. (2016) (124)
ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens (2013) (124)
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups. (2018) (113)
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. (2015) (112)
Integrative radiogenomic profiling of squamous cell lung cancer. (2013) (106)
Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy (2019) (102)
Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis (2012) (100)
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor (2018) (99)
GeneCluster 2.0: an advanced toolset for bioarray analysis (2004) (99)
A Curated Resource for Phosphosite-specific Signature Analysis* (2018) (93)
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. (2017) (91)
An expanded universe of cancer targets (2021) (86)
Characterizing genomic alterations in cancer by complementary functional associations (2016) (86)
Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. (2004) (84)
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. (2008) (81)
CDK 8 is a colorectal cancer oncogene that regulates b-catenin activity (2008) (77)
Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features. (2011) (74)
Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers (2013) (74)
Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. (2013) (73)
An Analytical Method for Multiclass Molecular Cancer Classification (2003) (72)
The limitations of simple gene set enrichment analysis assuming gene independence (2011) (66)
An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity (2012) (60)
Role of Tet1/3 Genes and Chromatin Remodeling Genes in Cerebellar Circuit Formation (2016) (59)
Gene signatures related to B‐cell proliferation predict influenza vaccine‐induced antibody response (2014) (57)
Visualizing and interpreting single-cell gene expression datasets with Similarity Weighted Nonnegative Embedding (2018) (52)
Joint Modeling and Registration of Cell Populations in Cohorts of High-Dimensional Flow Cytometric Data (2013) (49)
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets (2016) (48)
Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers. (2016) (46)
Portraits of breast cancer progression (2007) (46)
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers (2019) (45)
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer (2018) (45)
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy (2018) (44)
OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. (2017) (43)
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS. (2018) (42)
MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma (2012) (42)
The GenePattern Notebook Environment. (2017) (35)
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells (2020) (35)
HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers (2020) (35)
Cascades of transcriptional induction during human lymphocyte activation. (2001) (34)
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States. (2017) (33)
GeneCruiser: a web service for the annotation of microarray data (2005) (33)
Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials (2018) (31)
A Curated Resource for Phosphosite-specific Signature Analysis. (2019) (31)
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. (2015) (30)
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes. (2019) (27)
Metformin inhibits progression of Head and Neck Squamous Cell Carcinoma by acting Directly on Carcinoma Initiating Cells. (2019) (26)
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy (2020) (26)
Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors (2012) (25)
Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 Levels. (2016) (25)
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network (2017) (25)
A strategy for oligonucleotide microarray probe reduction (2002) (24)
Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation (2020) (24)
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma (2020) (21)
Integrative functional genomics identifies RINT1 as a novel GBM oncogene (2012) (18)
Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome (2012) (17)
Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers (2020) (16)
Macrophage Syk–PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual Syk–PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression (2020) (15)
Abstract S1-01: Whole exome and transcriptome sequencing of resistant ER+ metastatic breast cancer (2017) (13)
TEAD1 and TEAD3 play redundant roles in the regulation of human epidermal proliferation. (2020) (13)
High-throughput Phenotyping of Lung Cancer Somatic Mutations. (2016) (13)
Cancer Genomics and Molecular Pattern Recognition (2002) (13)
Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples (2020) (13)
SPT6 promotes epidermal differentiation and blockade of an intestinal-like phenotype through control of transcriptional elongation (2021) (11)
Genomic and Proteomic Alterations in Desmoplastic Small Round Blue-Cell Tumors. (2018) (10)
A Genome-Wide siRNA Screen in Mammalian Cells for Regulators of S6 Phosphorylation (2015) (10)
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma (2021) (9)
Breast cancer stratification from analysis of micro-array data of micro-dissected specimens. (2007) (8)
Gene Set Enrichment Analysis Made Right (2011) (8)
Characterization of Citrus tristeza virus isolates from Colombia (2013) (7)
Human induced pluripotent stem cell‐derived macrophages ameliorate liver fibrosis (2021) (7)
Modelling bistable tumour population dynamics to design effective treatment strategies. (2019) (7)
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4 (2012) (6)
Modelling bistable tumour population dynamics to design effective treatment strategies (2018) (6)
Ovarian Cancer Oncogene Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the (2012) (6)
WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer (2020) (5)
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma. (2021) (5)
The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo (2019) (5)
Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers (2019) (5)
Darwin : A Scalable Integrated System for Data Mining (1999) (5)
Microarray Data Analysis: Cancer Genomics and Molecular Pattern Recognition (2003) (5)
Constellation Map: Downstream visualization and interpretation of gene set enrichment results (2015) (4)
application to hematopoietic differentiation Interpreting patterns of gene expression with self-organizing maps: Methods and (2007) (4)
CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity (2022) (4)
Responses to immunotherapy in hepatocellular carcinoma patients with nonalcoholic steatohepatitis cirrhosis. (2022) (3)
Golub , Monitoring and Class Prediction by Gene Expression Molecular Classification of Cancer : Class Discovery (2007) (3)
KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor (2021) (3)
Analysis of CDK12 alterations in a pan‐cancer database (2021) (3)
A method for downstream analysis of gene set enrichment results facilitates the biological interpretation of vaccine efficacy studies (2016) (3)
Su.86. Automated High-dimensional Flow Cytometric Data Analysis (2008) (2)
Abstract 4868: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations within a wide spectrum of genetic heterogeneity (2012) (2)
Better Definition for Brainstem Tumors: Advances in Diffusion Tensor Imaging (2010) (2)
Cyclin E Overexpression in Human Mammary Epithelial Cells Promotes Epithelial Cancer-Specific Copy Number Alterations (2019) (2)
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. (2021) (2)
GNAS‐PKA Oncosignaling Network in Colorectal Cancer (2018) (2)
An Erythroid Differentiation Gene Expression Signature Predicts Response to Lenalidomide in Myelodysplasia. (2006) (1)
Abstract 968: Targeting FAK inhibits YAP-dependent tumor growth in uveal melanoma (2018) (1)
Abstract 1310: Systematic evaluation of gene networks for discovery of disease genes (2018) (1)
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation (2019) (1)
Abstract 1313: Mutually exclusive somatic mutations in WNT pathway medulloblastomas reveal a critical interaction between DDX3X and SMARCA4 (2012) (1)
Abstract 66: Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors (2011) (1)
CRRAO Advanced Institute of Mathematics, Statistics and Computer Science (AIMSCS) (2013) (1)
Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R, and GenePattern Notebook implementations of CoGAPS (2022) (1)
Microarray Data Analysis (2003) (1)
Visualizing single-cell RNA-seq datasets with Similarity Weighted Nonnegative Embedding (SWNE) (2018) (1)
Therapeutics , Targets , and Chemical Biology Integrative Radiogenomic Pro fi ling of Squamous Cell Lung Cancer (2013) (1)
Identifying novel molecular vulnerabilities to PTK2/FAK inhibition in G α q‐driven uveal melanoma using a kinome‐wide CRISPR/Cas9 screen (2019) (1)
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer (2018) (1)
Integrative Radiogenomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Adenocarcinomas of the Lung (2014) (1)
Abstract PR04: A melanoma transcriptional state distinction influences sensitivity to MAPK pathway inhibitors (2015) (1)
Gene Expression Studies May Identify Lower Risk Myelodysplastic Syndrome Patients Likely to Respond to Therapy with Ezatiostat Hydrochloride (TLK199) (2011) (1)
Abstract 1684: Multi-omics profiling of breast cancers during neoadjuvant chemotherapy identified distinct molecular changes and biomarkers associated with clinical response (2019) (0)
Abstract 3035: Decomposing oncogenic transcriptional signatures to generate maps of divergent cellular states (2017) (0)
Abstract 4760: Molecular classification and risk-stratification in medulloblastoma using an integrative genomic approach (2011) (0)
PD52-12 ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC) (2020) (0)
Immunotherapy treatment responses in hepatocellular carcinoma patients with nonalcoholic fatty liver disease cirrhosis. (2022) (0)
MB-27PATHWAY ANALYSIS OF A HUMAN NEURAL STEM CELL MODEL OF AGGRESSIVE MEDULLOBLASTOMA REVEALS CKD INBHIBITION AS A POTENTIAL THERAPEUTIC MODALITY (2015) (0)
Abstract PR12: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function (2015) (0)
GenePattern Notebooks: An integrative analytical environment for genomic research (2016) (0)
46. Data driven refinement of gene signatures for enrichment analysis and cell state characterization (2022) (0)
Comprehensive Genomic Profiling Reveals Complex and Distinct but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials (2018) (0)
Systematic Evaluation of M olecular Networks for Discovery of Disease Genes Graphical (2018) (0)
On the Parallelization of CHARMM on the CM-5/5E (1996) (0)
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor (2018) (0)
Characterization of advanced hepatocellular carcinoma patients via a multi-omic cancer registry. (2020) (0)
Abstract A09: Decomposing Oncogenic Transcriptional Signatures to Generate Maps of RAS/MAPK Cellular States (2017) (0)
Gαs (GNAS) suppression of the p53 genomic‐stability checkpoint unleashes RAS‐driven oncogenesis (2020) (0)
Abstract 4259: The radiogenomic landscape of cancer (2014) (0)
Abstract 3315: Functional genomic profiling of lung adenocarcinoma identifies BRAF mutations as novel therapeutic targets (2015) (0)
DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS (2018) (0)
Title: KRAS genomic status predicts the sensitivity of ovarian cancer cells to decitabine Running Title: KRAS status predicts sensitivity to decitabine in ovarian cancer Authors: Stewart ML, Tamayo (2015) (0)
MBRS-65. CHEMI-GENOMIC ANALYSIS OF PATIENT-DERIVED XENOGRAFTS TO IDENTIFY PERSONALIZED THERAPIES FOR MEDULLOBLASTOMA (2016) (0)
Abstract 3207: GenePattern Notebook: An integrative analytical environment for cancer research (2020) (0)
A Genetic Basis for Variation in the Vulnerability of Cancer to Ionizing Radiation (2016) (0)
Abstract B21: Childhood Cancer Molecular Map (C2M2) to define medulloblastoma heterogeneity and predict treatment response (2020) (0)
Abstract 2476: DiSCoVERing innovative therapies for rare tumors: Combining genetically accurate disease models with advanced in silico analysis to identify novel therapeutic targets (2016) (0)
Abstract #5608: Synthetic lethal interaction between oncogenic KRAS dependency and suppression of STK33 in human cancer cells (2009) (0)
Abstract 1903: GenePattern Notebook: An integrative analytical environment for cancer research (2016) (0)
MB-103DiSCoVERing INNOVATIVE THERAPIES: COMBINING GENETICALLY ACCURATE DISEASE MODELS OF MEDULLOBLASTOMA WITH ADVANCED IN SILICO ANALYSIS TO IDENTIFY NOVEL THERAPEUTIC TARGETS (2016) (0)
Abstract P5-06-02: A gene expression meta-analysis identifies microenvironment differences in cellular composition and cell-cell interactions associated with breast cancer invasion (2022) (0)
Abstract A23: An integrated platform for the functional annotation of the cancer genome (2009) (0)
Abstract 5865: The composition of the human ribosome varies significantly in different normal and malignant tissues (2020) (0)
Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network (2017) (0)
Differential Analysis of Stromal-Epithelial Interactions between In Situ and Invasive Breast Cancer using Gene Expression Profiling (2022) (0)
MBRS-30. TORC1/2 INHIBITION SENSITIZES MYC-DRIVEN MEDULLOBLASTOMA CELLS TO CARBOPLATIN CHEMOTHERAPY (2018) (0)
Metagene projection strategies for discovering mechanisms of T cell differentiation in gene expression profiling data (58.13) (2012) (0)
Systematic Investigation of Genetic Vulnerabilities Across Cancer Cell Lines Reveals Lineage Specific Radiotherapeutic Determinants (2015) (0)
Integrative Radiotranscriptomic Analysis of Breast Carcinoma Identifies Androgen Receptor as a Target for Therapeutic Sensitization (2015) (0)
NF-κB Activation in Breast Cancer Occurs Via Different Mechanisms in Triple Negative and HER2+ Tumors with Lymphocytic Infiltrate. (2009) (0)
Author response: STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells (2020) (0)
Data Preprocessing Data normalization , Imputation Gene Filtering PCA 85 % variation k-Level Ensemble Consensus Clustering (2007) (0)
A Functional Landscape o f Resistance to ALK Inhibition in Lung Cancer Graphical Abstract Highlights (2015) (0)
Abstract 1416: Pan-cancer mutual vulnerability and viability (2018) (0)
Abstract PR5: Treatment of ovarian cancer with targeted tumor-penetrating siRNA nanocomplexes (2012) (0)
Systematic loss of function screens identify pathway specific functional circular RNAs (2022) (0)
A strategy for oligonucleotide microarray probe reduction Citation (2002) (0)
A Combined Genetic Programming for Microarray Data Analysis (2020) (0)
MOTIVATING UNDERGRADUATE STUDENTS THE STUDY OF CHEMISTRY THROUGH A PRACTICAL PROBLEM SOLUTION (2014) (0)
Abstract 5032: Data driven refinement of gene signatures for enrichment analysis and cell state characterization (2022) (0)
GNAS‐PKA Oncosignaling Network in Colorectal Cancer (2017) (0)
NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer : Novel Therapies/Experimental Therapies (2014) (0)
Abstract PR04: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function (2015) (0)
NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer (2014) (0)
MOLECULAR CANCER THERAPEUTICS | TARGETING DRUG RESISTANCE KIT Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor (2021) (0)
Novel Computational Methods to Enhance the Analysis of Cytometric Immunophenotypes (2007) (0)
Diagnostic de tumeur cerebrale et prediction de resultat de traitement (2002) (0)
Discovery of novel candidate oncogenic pathway activators with REVEALER (2011) (0)
Abstract 1555: Pan-cancer patterns of synthetic lethality: statistical modeling of gene dependency profiles (2017) (0)
Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC). (2020) (0)
NF-κB activation in basal and HER2+ breast cancers occurs via different mechanisms (2008) (0)
Abstract 263: KITlowcells mediate Imatinib resistance and disease persistence in gastrointestinal stromal tumor (2019) (0)
The Radiogenomic Landscape of Cancer (2014) (0)
Abstract A20: Gαq controls the Hippo pathway through MOB1 tyrosine phosphorylation by FAK (2020) (0)
Comprehensive Genomic Profiling Identifies BRAF Mutations as Novel Radiotherapeutic Targets in Lung Adenocarcinoma (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pablo Tamayo?

Pablo Tamayo is affiliated with the following schools:

Pablo Tamayo's Academic­Influence.com Rankings

Pablo Tamayo's Degrees

Similar Degrees You Can Earn

Why Is Pablo Tamayo Influential?

Pablo Tamayo's Published Works

Published Works

What Schools Are Affiliated With Pablo Tamayo?

Pablo Tamayo's AcademicInfluence.com Rankings